The authors of this Viewpoint reframe the current controversy regarding the use of calcium-based versus non-calcium-based phosphate binders in patients on dialysis. They argue that clinicians ...

Phosphate binders. In the 1970s and ’80s, aluminum-containing phosphate binders were widely and effectively used, but recognition that aluminum caused encephalopathy, bone disease, refractory ...

To update their 2009 meta-analysis on the effect of calcium-based vs non-calcium-based phosphate binders on mortality in patients with CKD, Sophie A. Jamal, MD, and colleagues from the University ...

Although phosphate binders lower serum and urinary phosphorus and reduce progression of secondary hyperthyroidism, they also promote progression of vascular calcification, and consequently their ...

Washington Editor. A panel of kidney and cardiovascular experts Tuesday told the FDA that phosphate binders used to control serum phosphorus levels in patients with chronic kidney disease (CKD) on ...

The mean eGFR on study entry was 26.6 mL/min/1.73m 2, and the mean serum phosphate level was 1.25 mmol/L (3.87 mg/dL); 45% of participants had diabetes, and 32% had cardiovascular disease ...

While aluminum was an effective phosphate binder, it caused osteomalacia and adynamic bone disease. Specifically, aluminum impairs mineralization of the matrix by laying down crystals that ...

A third-generation artificial kidney has the potential to provide unprecedented wearability and convenience, enable freedom from phosphate binders and excessive dietary restrictions and produce a ...

DaVita reiterates 2025 guidance amid cyber incident and expects phosphate binders to contribute at upper end of range. May 12, 2025 9:42 PM ET DaVita Inc. (DVA) Stock AI-Generated Earnings Calls ...

DaVita reiterates 2025 guidance amid cyber incident and expects phosphate binders to contribute at upper end of range. 3w. Earnings Call Insights: DaVita Inc. (DVA) Q1 2025. Management View.